DE3381005D1 - Staemme des rinderdiarrhoeevirus, ihre herstellung und diese enthaltende vakzine. - Google Patents

Staemme des rinderdiarrhoeevirus, ihre herstellung und diese enthaltende vakzine.

Info

Publication number
DE3381005D1
DE3381005D1 DE8383870106T DE3381005T DE3381005D1 DE 3381005 D1 DE3381005 D1 DE 3381005D1 DE 8383870106 T DE8383870106 T DE 8383870106T DE 3381005 T DE3381005 T DE 3381005T DE 3381005 D1 DE3381005 D1 DE 3381005D1
Authority
DE
Germany
Prior art keywords
virus
bvd
beef
stem
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8383870106T
Other languages
English (en)
Inventor
Jean-Claude Delgoffe
Michele Lobmann
Nathan Zygraich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SMITHKLINE BECKMAN ANIMAL HEAL
Original Assignee
SMITHKLINE BECKMAN ANIMAL HEAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SMITHKLINE BECKMAN ANIMAL HEAL filed Critical SMITHKLINE BECKMAN ANIMAL HEAL
Application granted granted Critical
Publication of DE3381005D1 publication Critical patent/DE3381005D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24363—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE8383870106T 1982-10-13 1983-10-11 Staemme des rinderdiarrhoeevirus, ihre herstellung und diese enthaltende vakzine. Expired - Fee Related DE3381005D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/434,155 US4618493A (en) 1982-10-13 1982-10-13 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them

Publications (1)

Publication Number Publication Date
DE3381005D1 true DE3381005D1 (de) 1990-02-01

Family

ID=23723042

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383870106T Expired - Fee Related DE3381005D1 (de) 1982-10-13 1983-10-11 Staemme des rinderdiarrhoeevirus, ihre herstellung und diese enthaltende vakzine.

Country Status (16)

Country Link
US (1) US4618493A (de)
EP (1) EP0106831B1 (de)
JP (3) JPS5989631A (de)
AT (1) ATE48948T1 (de)
AU (1) AU572050B2 (de)
CA (1) CA1216234A (de)
DE (1) DE3381005D1 (de)
DK (1) DK170061B1 (de)
ES (2) ES8600058A1 (de)
FI (1) FI82264C (de)
GR (1) GR78966B (de)
IE (1) IE56438B1 (de)
NO (1) NO166953C (de)
NZ (1) NZ205491A (de)
PT (1) PT77454B (de)
ZA (1) ZA837573B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291228B1 (en) * 1988-08-03 2001-09-18 Vericore Limited Vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052606A (en) * 1958-08-30 1962-09-04 Behringwerke Ag Viral mutation with nitrites
US3293129A (en) * 1962-02-01 1966-12-20 Cornell Res Foundation Inc Immunization of cattle against virus diarrhea virus
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
GB1390467A (en) * 1973-03-30 1975-04-16 Rit Rech Ind Therapeut Vaccination method using temperature sensitive virus mutants
US3927208A (en) * 1973-05-14 1975-12-16 Rit Rech Ind Therapeut Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
JPS5817084B2 (ja) * 1978-08-25 1983-04-05 新明和工業株式会社 塵芥押込処理装置の操作装置

Also Published As

Publication number Publication date
PT77454B (en) 1986-02-26
DK472083D0 (da) 1983-10-13
ATE48948T1 (de) 1990-01-15
JPS5989631A (ja) 1984-05-23
NO166953C (no) 1991-09-18
GR78966B (de) 1984-10-02
JPH0773494B2 (ja) 1995-08-09
FI833717A0 (fi) 1983-10-12
US4618493A (en) 1986-10-21
FI833717A (fi) 1984-04-14
NO166953B (no) 1991-06-10
ES526380A0 (es) 1985-04-16
EP0106831A3 (en) 1986-01-22
ZA837573B (en) 1984-08-29
IE56438B1 (en) 1991-07-31
JPH05192139A (ja) 1993-08-03
FI82264B (fi) 1990-10-31
FI82264C (fi) 1991-02-11
IE832400L (en) 1984-04-13
EP0106831B1 (de) 1989-12-27
NO833717L (no) 1984-04-16
EP0106831A2 (de) 1984-04-25
JPH0463862B2 (de) 1992-10-13
ES8504929A1 (es) 1985-04-16
AU1852983A (en) 1984-04-19
DK170061B1 (da) 1995-05-15
ES526382A0 (es) 1985-10-01
JPH0773493B2 (ja) 1995-08-09
NZ205491A (en) 1989-07-27
CA1216234A (en) 1987-01-06
DK472083A (da) 1984-04-14
PT77454A (en) 1983-11-01
JPH05176764A (ja) 1993-07-20
AU572050B2 (en) 1988-04-28
ES8600058A1 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
DK0400958T3 (da) Levende vacciner
ATE326231T1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
Zygraich et al. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus
ATE20309T1 (de) Pharmazeutische zubereitung.
EP1438066A4 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
Andrei et al. An antiviral factor from Melia azedarach L. prevents Tacaribe virus encephalitis in mice
Shope Studies on immunity to swine influenza
JPS5576819A (en) Attenuated feline infectious peritonitis virus
DE3678749D1 (de) Verwendung von pollenextrakten zur herstellung von pharmazeutischen praeparaten zur prophylaktischen behandlung von allergien.
GB1413614A (en) Virus production
DE3381005D1 (de) Staemme des rinderdiarrhoeevirus, ihre herstellung und diese enthaltende vakzine.
Oxford The growth of rubella virus in small laboratory animals
Grachev Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union
RU92006181A (ru) Аттенуированный холодоадаптированный штамм вируса гриппа в/ссср/60/69 для получения живой интраназальной гриппозной вакцины
JPS5629525A (en) Preventive and remedy for infectious disease in intestine
KR840001515B1 (ko) 백신의 제조방법
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
Fribourg-Blanc et al. Congenital Syphilis
RU92006474A (ru) Аттенуированный холодоадаптированный штамм вируса гриппа ленинград /14/17/55 для получения штаммов живой интраназальной гриппозной вакцины
Takeda et al. The effects of a trichothecene, T-2 toxin, on growth of Japanese encephalitis virus in chick embryo cells and mice.
GB871838A (en) Purification of poliomyelitis virus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee